Evidence map›Paper›PMID 29782593›Full record

ArticleEuropean journal of hybrid imaging2018

Pacôme Fosse, Marie-Joelle Kaiser, Gauthier Namur, Dominique de Seny, Michel G Malaise, Roland Hustinx

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of hybrid imaging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Comparison of [AJNR. American journal of neuroradiology · 2019
    Trial
  2. Review
  3. Review
  4. Review
  5. Comparisons of [Clinical rheumatology · 2025
    Article
  6. Review
  7. Rheumatology advances in practice · 2025
    Article
  8. The Biodistribution and Utility ofNuclear medicine and molecular imaging · 2024
    Article
  9. Review
  10. Article
  11. EXPLORing Arthritis with Total-body Positron Emission Tomography.Seminars in musculoskeletal radiology · 2023
    Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Pacôme Fosse *3Division of Nuclear Medicine, University Hospital of Angers, Angers, France.
Marie-Joelle Kaiser *2Division of Rheumatology, University of Liège and CHU de Liège, Liège, Belgium.
Gauthier Namur1Division of Nuclear Medicine, University of Liège and CHU de Liège, Sart Tilman B35, 4000 Liège, Belgium.
Dominique de Seny2Division of Rheumatology, University of Liège and CHU de Liège, Liège, Belgium.
Michel G Malaise2Division of Rheumatology, University of Liège and CHU de Liège, Liège, Belgium.
Roland Hustinx1Division of Nuclear Medicine, University of Liège and CHU de Liège, Sart Tilman B35, 4000 Liège, Belgium.
University of Liège · BECentre Hospitalier Universitaire de Liège · BEUniversité d'Angers · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

resultsHigh interobserver agreement was observed, both at baseline and after treatment. The number of PET+ joints was not correlated with the number of joints tender or swollen. The 3 metabolic parameters were strongly correlated with US, CRP and DAS

conclusionsThese preliminary data suggest that

Indexed as

18F- FDGPET/CTRheumatoid arthritisRituximab

Identifiers

PMID29782593
PMCPMC5954768
OpenAlexW2797494384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.